These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 23061793

  • 1. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
    Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R.
    Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793
    [Abstract] [Full Text] [Related]

  • 2. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U, Wongsurakiat P, Pooruk P, Maranetra N, Puthavathana P.
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [Abstract] [Full Text] [Related]

  • 3. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V, Lu Y, Tan C, Camous XFN, Nyunt SZ, Carre C, Mok EWH, Wong G, Maurer-Stroh S, Abel B, Burdin N, Poidinger M, Tambyah PA, Bosco N, Visan L, Ng TP, Larbi A.
    Front Immunol; 2018 Jun; 9():2465. PubMed ID: 30405641
    [Abstract] [Full Text] [Related]

  • 4. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 5. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
    Skowronski DM, Tweed SA, De Serres G.
    J Infect Dis; 2008 Feb 15; 197(4):490-502. PubMed ID: 18275271
    [Abstract] [Full Text] [Related]

  • 6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 15; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.
    Vinnemeier CD, Fischer-Herr J, Meyer S, Liebig K, Theeß W, Burchard GD, Cramer JP.
    Hum Vaccin Immunother; 2014 Sep 15; 10(2):441-8. PubMed ID: 24240428
    [Abstract] [Full Text] [Related]

  • 8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep 15; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 9. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
    Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH.
    Vaccine; 2013 May 01; 31(19):2358-65. PubMed ID: 23499604
    [Abstract] [Full Text] [Related]

  • 10. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC.
    PLoS One; 2013 May 01; 8(8):e70866. PubMed ID: 23976960
    [Abstract] [Full Text] [Related]

  • 11. Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents.
    Kang EK, Eun BW, Kim NH, Kim YK, Lim JS, Kim DH.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):895-902. PubMed ID: 27905835
    [Abstract] [Full Text] [Related]

  • 12. Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents.
    Machado AA, Machado CM, Boas LS, Lopes MC, Gouvêa Ade F, Succi RC, Mendoza TR, Kanashiro TM, Machado DM.
    AIDS Res Hum Retroviruses; 2011 Sep 03; 27(9):999-1003. PubMed ID: 21284525
    [Abstract] [Full Text] [Related]

  • 13. Antibody response to influenza vaccination in nursing home residents and healthcare workers during four successive seasons in Niigata, Japan.
    Sato M, Saito R, Tanabe N, Nishikawa M, Sasaki A, Gejyo F, Suzuki H.
    Infect Control Hosp Epidemiol; 2005 Nov 03; 26(11):859-66. PubMed ID: 16323321
    [Abstract] [Full Text] [Related]

  • 14. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X.
    Hum Vaccin Immunother; 2015 Nov 03; 11(7):1648-53. PubMed ID: 26083828
    [Abstract] [Full Text] [Related]

  • 15. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
    Blanchard-Rohner G, Meier S, Bel M, Combescure C, Othenin-Girard V, Swali RA, Martinez de Tejada B, Siegrist CA.
    Pediatr Infect Dis J; 2013 Dec 03; 32(12):1374-80. PubMed ID: 24569309
    [Abstract] [Full Text] [Related]

  • 16. Effects of Banafine® , a fermented green banana-derived acidic glycoconjugate, on influenza vaccine antibody titer in elderly patients receiving gastrostomy tube feeding.
    Horie K, Hossain MS, Kim Y, Akiko I, Kon R, Yamatsu A, Kishima M, Nishikimi T, Kim M.
    J Food Sci; 2021 Apr 03; 86(4):1410-1417. PubMed ID: 33768522
    [Abstract] [Full Text] [Related]

  • 17. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.
    Vaccine; 2011 Nov 21; 29(50):9391-7. PubMed ID: 21983154
    [Abstract] [Full Text] [Related]

  • 19. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.
    Vaccine; 2012 Jun 22; 30(30):4543-51. PubMed ID: 22475864
    [Abstract] [Full Text] [Related]

  • 20. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
    Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, Vogel FR, Denis M, Samson SI, Icardi G.
    Vaccine; 2012 Apr 16; 30(18):2908-13. PubMed ID: 22342501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.